The Group is aware of its social, environmental, and economic impact and pays special attention to these themes, going beyond compliance with current regulations. The commitment to sustainability and the attention to the territory and to the people, consolidated over the years, is summarized in our Non-financial Disclosure 2020, which includes all the elements that

GVS has joined the United Nations Global Compact, the world’s largest voluntary initiative for business sustainability. The commitment to environmental, social, and economic sustainability shown by GVS Group has been consolidated over the years. The founding values of the Group, set out in the Code of Ethics, are the premise to integrate the ten universal principles,

QUALE INDOSSARE E COME INDOSSARLA MERCOLEDÌ 9 GIUGNO, DALLE ORE 12:00 – ALLE ORE 13:00 Il webinar è destinato a tutti gli operatori in ambito medicale. La partecipazione al corso é gratuita!   👉🏻 ISCRIVITI Guarda il Trailer https://youtu.be/iCf6Qwt57JI Formazione interattiva e dimostrazione pratica del corretto utilizzo in ambito sanitario delle maschere e degli strumenti a disposizione per una valutazione

GVS Sud Srl, Company owned by the GVS Group, participated in a project which has received funding from the European Union’s European Regional Development Fund, with the ambition to develop two multifunctional, biomimetic filters that will make it possible to capture leukocytes, pathogens and potassium ions from blood and blood products used for transfusions. The

Watch the video of a special moment: our debut on the Italian Stock Exchange! The first new listing of 2020 on the MTA, the main market of Borsa Italiana https://youtu.be/jrnSxRQTMKc

One of the main targets of blood transfusion safety is to avoid the Transfusion-transmitted infections (TTIs), which are infections resulting from the introduction of a pathogen into a patient through blood transfusion. Several strategies are applied step-by-step to ensure that the blood components are safe from pathogens before their transfusions. The virus inactivation treatment of blood components is a viral inactivation technology that can be applied through a blood bank process so

For many years GVS has been committed to taking action to improve the sustainability of its business management. As evidence of this, the Company has been awarded the Silver Medal for Sustainability by EcoVadis, a leading company in the assessment of Corporate Social Responsibility (CSR), ranking in the top 25% best companies analyzed in 2021.

GVS Group has always supported various institutions and associations engaged in helping those in difficulty and in supporting research, paying particular attention to charitable and non-profit organizations active in its territory. In addition to the various associations supported, there is also the “Fondazione per lo Sport Silvia Parente”, a non-profit organization that manages, supports and

The acquisition, carried out by GVS Mexico, will strengthen the Group’s presence in the Life Sciences industry GVS Filter Technology de Mexico, based in Monterrey (Mexico) and part of GVS Group, has acquired the syringe filter product business from Graphic Controls Acquisition Corp. The acquisition includes products, currently manufactured in Buffalo, New York, and marketed

On June 3rd 2020 GVS S.p.A. signed an agreement to acquire Haemonetics’ plant in Fajardo and to supply and develop blood filters for Haemonetics Today our Group announced that it has entered into an agreement to acquire Haemonetics’ Fajardo, Puerto Rico, manufacturing operations and to supply and develop blood filters for Haemonetics. The combination of